Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000691

Drug Information
NameAmediplase
Synonymstrans,trans-3,4:12,13-Tetrahydroxy-3,4,12,13-tetrahydro-dibenz(a,h)anthracene; 151910-75-7; CCRIS 8205; AC1L4CPU; LS-189263; 151912-11-7; Amediplase; CID154656; (3S,4S,12S,13S)-3,4,12,13-tetrahydronaphtho[1,2-b]phenanthrene-3,4,12,13-tetrol; Amediplase [INN]
CompanyMenarini
IndicationThrombolysis
[ICD9: 410, 415.1, 434.91, 459.9   ICD10: I21-I22, I26, I61-I63, I99.9]
Phase III    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C22H18O4/c23-19-8-7-13-15(20(19)24)6-5-11-9-17-12-3-1-2-4-14(1
2)21(25)22(26)18(17)10-16(11)13/h1-10,19-26H/t19-,20-,21-,22-/m0/
s1
InChIKeyYQINXCSNGCDFCQ-CMOCDZPBSA-N
Canonical SMILESC1=CC=C2C(=C1)C(C(C3=C2C=C4C=CC5=C(C4=C3)C=CC(C5O)O)O)O    
Isomeric SMILESC1=CC=C2C(=C1)[C@@H]([C@H](C3=C2C=C4C=CC5=C(C4=C3)C=C[C@@H]([C@H]5O)O)O)
O
CAS NumberCAS 151912-11-7
FormulaC22H18O4
PubChem Compound IDCID 154656.
PubChem Substance IDSID 732057.
SuperDrug ATC IDB01AC07
SuperDrug CAS ID000058322;
TargetUrokinase-type plasminogen activatorActivator[1]
Ref 1Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543